- Home
- STNG vs AMRX Comparison
STNG vs AMRX Comparison
Compare STNG & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STNG
- AMRX
- Stock Information
- Founded
- STNG 2009
- AMRX 2002
- Country
- STNG Monaco
- AMRX United States
- Employees
- STNG N/A
- AMRX N/A
- Industry
- STNG Marine Transportation
- AMRX Biotechnology: Pharmaceutical Preparations
- Sector
- STNG Consumer Discretionary
- AMRX Health Care
- Exchange
- STNG Nasdaq
- AMRX Nasdaq
- Market Cap
- STNG 3.2B
- AMRX 3.3B
- IPO Year
- STNG 2010
- AMRX N/A
- Fundamental
- Price
- STNG $61.79
- AMRX $11.62
- Analyst Decision
- STNG Strong Buy
- AMRX Buy
- Analyst Count
- STNG 5
- AMRX 3
- Target Price
- STNG $69.00
- AMRX $12.67
- AVG Volume (30 Days)
- STNG 690.0K
- AMRX 1.8M
- Earning Date
- STNG 10-30-2025
- AMRX 10-30-2025
- Dividend Yield
- STNG 2.72%
- AMRX N/A
- EPS Growth
- STNG N/A
- AMRX N/A
- EPS
- STNG 5.88
- AMRX 0.02
- Revenue
- STNG $889,539,000.00
- AMRX $2,934,959,000.00
- Revenue This Year
- STNG N/A
- AMRX $10.20
- Revenue Next Year
- STNG $3.05
- AMRX $6.95
- P/E Ratio
- STNG $10.52
- AMRX $620.20
- Revenue Growth
- STNG N/A
- AMRX 9.50
- 52 Week Low
- STNG $30.63
- AMRX $6.69
- 52 Week High
- STNG $65.52
- AMRX $12.12
- Technical
- Relative Strength Index (RSI)
- STNG 56.77
- AMRX 63.04
- Support Level
- STNG $61.28
- AMRX $11.29
- Resistance Level
- STNG $63.21
- AMRX $12.12
- Average True Range (ATR)
- STNG 2.08
- AMRX 0.45
- MACD
- STNG -0.13
- AMRX 0.06
- Stochastic Oscillator
- STNG 47.91
- AMRX 77.70
About STNG Scorpio Tankers Inc.
Scorpio Tankers Inc is a provider of marine transportation of petroleum products. It owned, lease financed, or chartered in vessels spanning three different vessel segments Handymax, MR, and LR2. The company's fleet of tankers is the eco-friendly, and newest fleet on the water hauling clean petroleum products. It provides seaborne transportation of crude oil and refined petroleum products. The company generates the majority of its revenue from LR2.
About AMRX Amneal Pharmaceuticals Inc.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.